Literature DB >> 32148839

Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage.

Hisao Higo1, Noriyuki Suzaki1, Takuya Nagata1, Taro Togami2, Nobuya Ohara3, Masaomi Marukawa1.   

Abstract

Diagnosis in cases with pulmonary lymphangitic carcinomatosis as a primary manifestation is difficult due to unawareness of the cancer. An 81-year-old man was admitted due to a one-week history of dyspnoea and haemoptysis. Chest computed tomography showed diffuse bilateral ground-grass opacity and partial consolidation. We suspected diffuse alveolar haemorrhage. High-dose methylprednisolone and cyclophosphamide did not improve his condition and he died from respiratory failure. Autopsy revealed pulmonary lymphangitic carcinomatosis of whole lungs and primary gallbladder cancer. We should consider pulmonary lymphangitic carcinomatosis in the differential diagnosis of patients with haemoptysis and diffuse lung opacity of unknown origin.
© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  Diffuse alveolar haemorrhage; gallbladder cancer; haemoptysis; pulmonary lymphangitic carcinomatosis

Year:  2020        PMID: 32148839      PMCID: PMC7026625          DOI: 10.1002/rcr2.540

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


Introduction

Pulmonary lymphangitic carcinomatosis is caused by lymphatic spreading of metastatic cancer cells in the lungs. Most patients present with subacute, progressive dyspnoea. A previous study reported an incidence of lung metastases of 6–8% in patients with cancer 1. We should consider lymphangitic carcinomatosis as one of the possible diagnoses in case of progressive dyspnoea complaints in patients with cancer. However, sometimes, the diagnosis is difficult when the primary manifestation is pulmonary lymphangitic carcinomatosis, because we are unaware of the cancer.

Case Report

An 81‐year‐old Japanese man was admitted to our hospital due to haemoptysis and dyspnoea lasting for a week. He had occupational history of asbestos exposure. On admission, his body temperature was 37.2°C and O2 saturation was 86%. Bilateral fine crackles were heard on chest auscultation. Chest X‐ray showed diffuse bilateral ground‐grass opacity and consolidation and blunting of the bilateral costophrenic sulci (Fig. 1A). Chest computed tomography (CT) revealed diffuse bilateral ground‐grass opacity and partial consolidation with upper lobe predominance (Fig. 1B, C). Smooth thickened interlobular septa were seen only in the bilateral lung apexes (Fig. 1B). Mediastinal lymphadenopathy, bilateral pleural effusions, and pleural plaques were also observed. Laboratory findings demonstrated leucocytosis (9100/μL) and elevated serum C‐reactive protein level (4.2 mg/dL), while platelet count, prothrombin time‐international normalized ratio, and activated partial thromboplastin time were normal. Serum anti‐dsDNA and anti‐Sm antibody levels were elevated (40.2 and 20.4 IU/mL, respectively), but there were no physical findings suggesting systemic lupus erythematosus. Antineutrophil cytoplasmic autoantibodies and anti‐glomerular basement membrane antibody were negative. Thoracentesis revealed that the pleural fluid was exudative, with lymphocytic predominance (93%). Cytology of the pleural fluid was negative. Tazobactam/piperacillin was administered from the first hospital day, but with no effect. On the basis of the chest CT findings and the persisting haemoptysis, we suspected diffuse alveolar haemorrhage. Bronchoscopy was not performed because his consent was not obtained due to severe dyspnoea. Methylprednisolone 1 g/day intravenously for three days followed by prednisolone 0.5 mg/kg was administered from the second hospital day. However, haemoptysis and dyspnoea were not improved. High‐resolution CT (HRCT) was performed on the hospital day 7. The area of ground‐grass opacity and consolidation was expanded and the thickened interlobular septa were slightly irregular (Fig. 1D, E). We repeated high‐dose methylprednisolone therapy as described above and added cyclophosphamide on hospital day 9. Despite the treatment, the patient's condition did not improve and he died of respiratory failure on hospital day 21.
Figure 1

Chest X‐ray and computed tomography (CT) on admission. (A) Chest X‐ray showed bilateral ground‐grass opacity, consolidation, and blunting of the bilateral costophrenic sulci. (B, C) Chest CT revealed bilateral ground‐grass opacity and partial consolidation with upper lobe predominance. Smooth thickened interlobular septa were seen only in the bilateral lung apexes (arrows). (D, E) High‐resolution CT on hospital day 7. The thickened interlobular septa were slightly irregular (arrow).

Chest X‐ray and computed tomography (CT) on admission. (A) Chest X‐ray showed bilateral ground‐grass opacity, consolidation, and blunting of the bilateral costophrenic sulci. (B, C) Chest CT revealed bilateral ground‐grass opacity and partial consolidation with upper lobe predominance. Smooth thickened interlobular septa were seen only in the bilateral lung apexes (arrows). (D, E) High‐resolution CT on hospital day 7. The thickened interlobular septa were slightly irregular (arrow). Autopsy revealed marked cancer metastases with vessel invasion and pulmonary lymphangitic carcinomatosis of the whole lungs (Fig. 2). There were no findings suggesting vasculitis or alveolar haemorrhage. Poorly differentiated adenocarcinoma was found in the gallbladder, which had infiltrated the hepatic hilar region and the right liver lobe. Infiltration of the pancreas, duodenum, and stomach, and cancer metastasis to the bilateral adrenal grand were also seen. A final diagnosis of pulmonary lymphangitic carcinomatosis from gallbladder cancer was made.
Figure 2

Histological autopsy findings. (A, B) Marked cancer metastasis with vessel invasion and pulmonary lymphangitic carcinomatosis of the lungs were seen (haematoxylin and eosin staining). Scale bar = 1 mm and 20 μm. (C) Immunohistochemistry of D2‐40, which detects lymphatic vessels, confirmed that the lymphatic vessels were filled with cancer cells. Scale bar = 20 μm.

Histological autopsy findings. (A, B) Marked cancer metastasis with vessel invasion and pulmonary lymphangitic carcinomatosis of the lungs were seen (haematoxylin and eosin staining). Scale bar = 1 mm and 20 μm. (C) Immunohistochemistry of D2‐40, which detects lymphatic vessels, confirmed that the lymphatic vessels were filled with cancer cells. Scale bar = 20 μm.

Discussion

Although rarely, cancer may present with pulmonary lymphangitic carcinomatosis as a primary manifestation. If an extrathoracic organ is the primary site, there is a possibility of misdiagnosis due to unawareness of the cancer. There have been reports on such misdiagnosed cases mimicking interstitial lung disease 2, sarcoidosis 3, and military tuberculosis 4. The most common complaint in these patients was cough or dyspnoea, whereas in our case, the patient had continuous haemoptysis and was misdiagnosed with diffuse alveolar haemorrhage. This case had some features similar to those of diffuse alveolar haemorrhage. The patient had typical symptoms, haemoptysis and dyspnoea, with acute onset 5, 6. Bilateral fine crackles were heard on chest auscultation, which is also compatible with the disease 7. The most common CT findings of diffuse alveolar haemorrhage are patchy ground‐glass opacities and consolidation on the bilateral lungs 8. Thickening of the intralobular septa is also sometimes seen in diffuse alveolar haemorrhage 9. All these features were noted in the present case. In addition, serum antibodies suggesting systemic lupus erythematosus, which could induce diffuse alveolar haemorrhage, were positive. On the other hand, there were features that made it difficult to diagnose pulmonary lymphangitic carcinomatosis. First, haemoptysis is a relatively rare symptom in pulmonary lymphangitic carcinomatosis. Common symptoms of this disease are dyspnoea and cough 10. Second, pleural fluid cytology was negative. Pleural dissemination was not seen on autopsy, but the cause of pleural effusion was thought to be increased pleural permeability or decreased lymphatic flow due to the cancer 11. Third, although the origin site of the pulmonary lymphangitic carcinomatosis was the gallbladder, the patient did not have any symptoms related to the primary disease. The most common complaints in patients with gallbladder cancer are pain under the right ribs, weight loss, anorexia, nausea, and vomiting 12. For these reasons, it was difficult to make a correct diagnosis. However, we should have suspected pulmonary lymphangitic carcinomatosis because HRCT revealed slightly irregular thickness of the interlobular septa, although conventional CT did not detect the irregularity. Irregular thickness of the interlobular septa is a relatively specific feature of lymphangitic carcinomatosis 10, 13. If bronchoscopy could have been performed, we might have reached a correct diagnosis. Bronchoalveolar lavage was reported to be useful in the diagnosis of pulmonary lymphangitic carcinomatosis 14, 15 as well as diffuse alveolar haemorrhage 9, 16. In conclusion, we reported a rare case of pulmonary lymphangitic carcinomatosis mimicking diffuse alveolar haemorrhage. To the best of our knowledge, this is the first report of pulmonary lymphangitic carcinomatosis as the first manifestation of gallbladder cancer. We should consider pulmonary lymphangitic carcinomatosis in the differential diagnosis when encountering patients with haemoptysis and diffuse lung opacity of unknown origin, even in cases without past history of cancer.

Disclosure Statement

Appropriate written informed consent was obtained for publication of this case report and accompanying images.
  16 in total

1.  Pulmonary lymphangitic carcinomatosis presenting as severe interstitial lung disease in a 15-year-old female.

Authors:  F J Gilchrist; H Alton; M-A Brundler; L Edwards; A Plunkett; S Rao
Journal:  Eur Respir Rev       Date:  2011-09-01

2.  Malignant pleural effusion: would the real cause please stand up?

Authors:  R W Light; H Hamm
Journal:  Eur Respir J       Date:  1997-08       Impact factor: 16.671

Review 3.  Diffuse pulmonary hemorrhage: clues to the diagnosis.

Authors:  John P Lichtenberger; Subba R Digumarthy; Gerald F Abbott; Jo-Anne O Shepard; Amita Sharma
Journal:  Curr Probl Diagn Radiol       Date:  2014 May-Jun

Review 4.  Carcinoma of the gallbladder.

Authors:  Sanjeev Misra; Arun Chaturvedi; Naresh C Misra; Indra D Sharma
Journal:  Lancet Oncol       Date:  2003-03       Impact factor: 41.316

5.  Pulmonary lymphangitic carcinomatosis: CT and pathologic findings.

Authors:  P L Munk; N L Müller; R R Miller; D N Ostrow
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

6.  Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018.

Authors:  Monika Klimek
Journal:  Postgrad Med       Date:  2019-04-05       Impact factor: 3.840

Review 7.  Imaging of pulmonary vasculitis.

Authors:  Man Pyo Chung; Chin A Yi; Ho Yun Lee; Joungho Han; Kyung Soo Lee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

Review 8.  Lymphangitis carcinomatosa: a literature review.

Authors:  D M Bruce; S D Heys; O Eremin
Journal:  J R Coll Surg Edinb       Date:  1996-02

9.  Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts.

Authors:  A De Lassence; J Fleury-Feith; E Escudier; J Beaune; J F Bernaudin; C Cordonnier
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

Review 10.  Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features.

Authors:  S L Primack; R R Miller; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1995-02       Impact factor: 3.959

View more
  2 in total

1.  Lymphangitis carcinomatosa from gallbladder cancer.

Authors:  Yoshihiro Kitahara; Daiki Taniyama; Kazuya Kuraoka; Akihisa Saito; Junichi Zaitsu; Kenichi Oga; Misato Senoo; Yusuke Araki; Atsushi Yamaguchi; Kikuo Nakano
Journal:  Respir Med Case Rep       Date:  2022-03-11

2.  Pulmonary lymphatic involvement in metastatic uterine sarcomas: imaging and pathological appearance.

Authors:  Takahiro Kitayama; Takashi Tanaka; Takao Hiraki; Shinichi Toyooka; Hiroyuki Yanai; Susumu Kanazawa
Journal:  Radiol Case Rep       Date:  2021-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.